Package Leaflet: Information for the User
Dariante 1 mg/24 h Transdermal Patches EFG
Dariante 3 mg/24 h Transdermal Patches EFG
rotigotine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
What is Dariante
Dariante contains the active substance rotigotine.
It belongs to a group of medicines known as “dopamine agonists”. Dopamine is an important messenger in the brain for movement.
What is Dariante used for
Dariante is used in adults to treat the signs and symptoms of:
Do not use Dariante if:
You must remove the rotigotine patch just before having an MRI scan or cardioversion to avoid skin burns because the patch contains aluminum. You can put on a new patch when these tests are over.
Do not use rotigotine if any of the above applies to you. If you are not sure, talk to your doctor, pharmacist, or nurse first.
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before you start using rotigotine. Because:
Medicines used to treat Restless Legs Syndrome should be reduced or stopped gradually. Tell your doctor if, after stopping or reducing your treatment with rotigotine, you experience symptoms such as depression, anxiety, fatigue, sweating, or pain.
You may lose consciousness
Rotigotine may cause loss of consciousness. This can happen especially when you start treatment with rotigotine or when the dose is increased. Tell your doctor if you lose consciousness or feel dizzy.
Changes in behavior and abnormal thoughts
Rotigotine may cause side effects that change your behavior (how you act). If your family or caregiver, or your doctor, are concerned about changes in your behavior, it may be helpful to tell a family member or caregiver that you are using this medicine and to read the leaflet. Tell your doctor if you, your family, or caregiver notice that you are using the medicine excessively or that you feel a strong need to take large doses of rotigotine or other medicines used to treat Restless Legs Syndrome.
For more information, see ‘Changes in behavior and abnormal thoughts’ in section 4.
Children and adolescents
This medicine must notbe given to childrenunder 18 years because its safety and efficacy in this age group are not known.
Other medicines and Dariante
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. This includes medicines without a prescription and herbal medicines.
Do not take the following medicines while you are using rotigotine - as they may reduce its effect:
Tell your doctor before using rotigotine if you are taking:
Your doctor will tell you if it is safe to take these medicines while you are using rotigotine.
Using Dariante with food, drinks, and alcohol
Since rotigotine enters the bloodstream through the skin, taking food or drinks does not affect how this medicine is absorbed. You should ask your doctor if you can drink alcohol while using rotigotine.
Pregnancy and breastfeeding
Do not use rotigotine if you are pregnant. This is because the effects of rotigotine on pregnancy and the fetus are not known.
Do not breastfeed while you are using rotigotine. This is because rotigotine may pass into breast milk and affect your baby. It may also reduce the amount of milk produced.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, ask your doctor or pharmacist for advice before using this medicine.
Driving and using machines
Rotigotine may make you feel very sleepy and you may fall asleep suddenly. If this happens, do not drive. In rare cases, some people have fallen asleep while driving, which has led to accidents.
Also, do not use tools or machines if you feel very sleepy - or perform any activity where you could put yourself or others at risk of serious injury.
Follow the instructions for administration of this medicine exactly as told by your doctor or pharmacist. If you are not sure, ask your doctor or pharmacist.
Which patch dose to use
Rotigotine is available in patches of different doses that release the medicine over 24 hours. The doses are 1 mg/24 h, 2 mg/24 h, and 3 mg/24 h for the treatment of Restless Legs Syndrome.
If you have to stop taking this medicine, see “If you stop using Dariante” in section 3.
How to use the Dariante patches:
Rotigotine is a patch that you apply to your skin.
Where to apply the patch
Apply the adhesive side of the patch to clean, dry, and healthy skin on the following areas, as indicated by the gray areas in the drawing:
To avoid skin irritation
|
If you continue to have skin problems caused by the patch, see “Skin problems caused by the patch” in section 4 for more information.
To prevent the patch from coming off or falling off
If the patch falls off, apply a new one for the rest of the day and the next day, apply a new patch at the usual time.
How to use the patch
| |
| |
| |
Remove the protective layer from the top of the patch, which is the color of cinnamon, and discard it. A transparent protective liner (release liner) covers the adhesive side of the patch. | |
| |
| |
Hold it for about 30 seconds. This ensures that the patch is in contact with your skin and the edges adhere well. Wash your hands with water and soap immediately after handling the patch. |
How to remove the used patch
If you use more Dariante than you should
Using higher doses of rotigotine than your doctor has told you may cause side effects such as nausea or vomiting, low blood pressure, seeing or hearing things that are not real (hallucinations), confusion, extreme sleepiness, involuntary movements, and convulsions. In these cases, tell your doctor or go to the hospital as soon as possible. They will tell you what to do.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to change the patch at the usual time
In both cases, the next day, apply a new patch at the usual time. Do not use a double dose to make up for forgotten doses.
If you stop using Dariante
Do not stop using rotigotine without talking to your doctor first. Stopping suddenly could cause a condition called ‘neuroleptic malignant syndrome’ that can put your life at risk. The signs include: loss of muscle movement (akinesia), muscle stiffness, fever, unstable blood pressure, increased heart rate (tachycardia), confusion, decreased consciousness (e.g., coma).
If your doctor tells you to stop using rotigotine, the daily doseof rotigotine should be gradually reduced:
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Tell your doctor, pharmacist, or nurse if you notice any side effects.
Most likely side effects at the start of treatment
You may have nauseaand vomitingat the start of treatment. These effects are usually mild or moderate and do not last long. You should consult your doctorif the effects last a long time or if they worry you.
Skin problems caused by the patch
You may experience loss of consciousness
Rotigotine may cause loss of consciousness. This can happen especially when starting treatment with rotigotine or when increasing the dose. Inform your doctor if you lose consciousness or feel dizzy.
Changes in behavior and abnormal thoughts
Tell your doctor if you notice any change in behavior, thinking, or both, as indicated below.
Your doctor will tell you how to manage or reduce the symptoms.
If your family or caregiver, or your doctor, are concerned about changes in your behavior, it may be helpful to tell a family member or caregiver that you are using this medication and to read the package insert. Rotigotine may cause anxiety or an overwhelming urge to behave abnormally and be unable to control the impulse, attack, or temptation to perform certain actions that may harm you or others.
These actions may include:
Rotigotine may cause other abnormal behaviors and thoughts, including:
Tell your doctor if you notice any change in your behavior, thinking, or both, as indicated above.Your doctor will tell you how to manage or reduce the symptoms.
Allergic reactions
Tell your doctor if you notice signs of an allergic reaction – which may include swelling of the face, tongue, or lips.
Adverse effects if you use rotigotine for Restless Legs Syndrome
Tell your doctor or pharmacist if you experience any of the following adverse effects:
Very common: may affect more than 1 in 10 patients
Common: may affect up to 1 in 10 patients
Uncommon: may affect up to 1 in 100 patients
Rare: may affect up to 1 in 1,000 patients
Not known: frequency not known
Tell your doctor or pharmacist if you experience any of these adverse effects.
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this package insert. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines (www.notificaram.es). By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and on the blister pack after "EXP". The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
What to do with used and unused patches
Composition of Dariante
The active ingredient is rotigotine.
A patch releases 1 mg of rotigotine every 24 hours. Each 4.6 cm2 patch contains 1.84 mg of rotigotine.
A patch releases 3 mg of rotigotine every 24 hours. Each 13.8 cm2 patch contains 5.52 mg of rotigotine.
The other components are:
Appearance of the product and package contents
Dariante is a transdermal patch. It is thin, square in shape with rounded corners. The outer part is brown in color and bears the inscription:
1 mg/24h: "Rotigotine 1 mg/24h"
3 mg/24h: "Rotigotine 3 mg/24h"
Dariante is available in the following formats:
Packages containing 7, 14, 28, 30, or 84 (multiple package containing 3 packages of 28) patches, each patch is included in an individual blister pack.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Exeltis Healthcare, S.L.
Avenida de Miralcampo, 7
Polígono Industrial Miralcampo
19200 Azuqueca de Henares
Guadalajara, Spain
Manufacturer
Luye Pharma AG
Am Windfeld 35
83714 Miesbach
Germany
This medication is authorized in the Member States of the European Economic Area under the following names:
Germany: Rotigotin Luye 1 mg/24 Stunden Transdermales Pflaster
Rotigotin Luye 3 mg/24 Stunden Transdermales Pflaster
Spain: Dariante 1 mg/24 h transdermal patches EFG
Dariante 3 mg/24 h transdermal patches EFG
Italy: Rotigotina Luye 1 mg/ore cerotto transdermico
Rotigotina Luye 3 mg/ore cerotto transdermico
Date of the last revision of this package insert:July 2023
Other sources of information
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The average price of DARIANTE 1 mg/24 hours TRANSDERMAL PATCHES in October, 2025 is around 37.47 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.